RxDoctor Payments DataLook up a doctor →

David Francyk, DO

Family Medicine · Phoenix, AZNPI 1073799813

Payments from drug & device makers

$1,269,224in general payments, 2019–2025

Across 972 payments — averaging $1305.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$803K
  • Eli Lilly$236K
  • Alnylam Pharmaceuticals Inc.$62K
  • AstraZeneca$50K
  • Sanofi US Services Inc.$47K
  • Novo Nordisk AS$36K
  • plus $35K from 54 others
$15,023in research payments, 2019–2025

Across 12 payments — averaging $1251.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14K
  • AbbVie$984

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.47$802,837
Eli Lilly7$236,117
Alnylam Pharmaceuticals Inc.19$61,740
AstraZeneca43$50,171
Sanofi US Services Inc.31$47,353
Novo Nordisk AS12$36,176
Regeneron8$11,475
GSK45$8,831
AbbVie(2 entities)146$2,423
Novo Nordisk101$1,641
Amgen55$1,190
Lexicon Pharmaceuticals, Inc.1$1,011
Lilly USA, LLC53$848
Merck30$744
Pfizer55$672
Johnson & Johnson26$541
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$444
Boehringer Ingelheim25$435
Abbott21$423
Boston Scientific9$329
Gilead15$294
Nestle Healthcare Nutrition Inc.23$291
Aimmune Therapeutics, Inc.11$245
Lucid Diagnostics Inc.6$200
Takeda Pharmaceuticals U.S.A., Inc.21$190
Corcept Therapeutics6$150
Viiv Healthcare Company6$149
Sanofi-aventis U.S. LLC9$136
Sumitomo Pharma America, Inc.5$135
E.r. Squibb & Sons, L.L.C.8$131
Impel Pharmaceuticals Inc.6$125
Mayne Pharma Commercial LLC1$122
Astellas Pharma US Inc6$115
Upsher-smith Laboratories LLC7$110
Novartis5$95
Otsuka America Pharmaceutical, Inc.4$88
Tolmar, Inc.5$86
Almatica Pharma LLC5$82
Vanda Pharmaceuticals Inc.5$81
Amarin Pharma, Inc.4$69
Currax Pharmaceuticals LLC3$63
Medtronic(2 entities)3$54
Edwards Lifesciences2$51
Alfasigma USA, Inc.3$47
Philips North America LLC2$45
Axsome Therapeutics, Inc.3$43
Biohaven Pharmaceuticals, Inc.3$42
IBSA Pharma Inc.2$42
Verity Pharmaceuticals Inc.2$38
Napo Pharmaceuticals Inc2$38
Stryker1$36
Strongbridge US Inc.2$35
Lundbeck LLC2$34
Phadia US Inc.2$30
Atricure, Inc.1$30
Bausch Health US, LLC2$29
Exact Sciences2$28
Daiichi Sankyo Inc.1$28
Vertex1$27
Inspire Medical Systems, Inc.1$24

How this compares

$1,269,224 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$317,178
Medicare patients
380
Services billed
6,690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →